RESOLVE THERAPEUTICS
Resolve Therapeutics is a private biotechnology company that is dedicated to the goal of improving the lives of patients suffering from lupus. They are focused on the advancement their exciting, novel biologic compound, RSLV-125 from preclinical research through a phase IIa clinical trial. The company is based on the pioneering discoveries made by Dr. Keith Elkon and Dr. Jeff Ledbetter in their laboratories at the University of Washington School of Medicine.
RESOLVE THERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2010-01-01
Address:
Kirkland, Washington, United States
Country:
United States
Website Url:
http://www.resolvebio.com
Total Employee:
1+
Status:
Active
Contact:
425-576-4100
Total Funding:
8.88 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Google Google Cloud
Current Advisors List
Board_member
Board_observer
Current Employees Featured
Raj Dua Managing the CMC @ Resolve Therapeutics
Managing the CMC
James Posada Co-Founder and CEO @ Resolve Therapeutics
Co-Founder and CEO
2010-04-01
Founder
Investors List
New Science Ventures
New Science Ventures investment in Series B - Resolve Therapeutics
Washington Research Foundation
Washington Research Foundation investment in Series B - Resolve Therapeutics
Easton Capital
Easton Capital investment in Series B - Resolve Therapeutics
New Science Ventures
New Science Ventures investment in Series A - Resolve Therapeutics
Easton Capital
Easton Capital investment in Series A - Resolve Therapeutics
Official Site Inspections
http://www.resolvebio.com
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 13.248.243.5
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Resolve Therapeutics"
Resolve Biosciences
Mar 15, 2023 · Our Molecular Cartography platform is a groundbreaking multi-analyte, highly multiplex spatial analysis technology that enables scientists to resolve the most complex …See details»
Meet – Resolve Biosciences
Resolve Biosciences is privately held and headquartered in Monheim am Rhein, Germany. The $24 million Series A financing round was led by PS Capital Management and MasterMind …See details»
Resolve BioSciences - Crunchbase Company Profile
Resolve Biosciences is a biotechnology research company for molecular cartography. View contacts for Resolve BioSciences to access new leads and connect with decision-makers.See details»
Resolution Bioscience
Longitudinal monitoring offers the ability to monitor tumor evolution over time and under treatment. Allelic frequencies can change quickly. At disease progression, it becomes critical to have a …See details»
Resolve Biosciences Launches Commercial Molecular …
Jun 2, 2021 · MONHEIM AM RHEIN, Germany, and SAN JOSE, Calif. – June 2, 2021 – Resolve Biosciences today announced the commercial launch of its groundbreaking Molecular …See details»
Resolve Biosciences - LinkedIn
Resolve Biosciences is applying the power of Molecular Cartography™ to enable scientists to gain new insights based on the highest-resolution view of single-cell spatial biology.See details»
Resolve BioSciences - Welcome!
Here, we provide access for registered customers to design panels, manage service projects, and analyze and visualize data. Please check our main website for information about our company, …See details»
Resolution Bioscience - LinkedIn
Resolution Bioscience, a part of Agilent, is pioneering next generation cancer diagnostics that enable physicians to tailor treatments for each patient using only a blood test — a liquid biopsy.See details»
Resolve Biosciences Secures $71 Million Series B Financing to ...
Oct 24, 2022 · Resolve Biosciences is applying the power of Molecular Cartography™ to enable scientists to gain new insights based on the highest-resolution view of spatial biology.See details»
Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis
Dec 10, 2020 · Resolve Biosciences announces $24 million Series A financing and appoints Jason T. Gammack as CEO to accelerate development and commercialization of Molecular …See details»
Resolve Biosciences Sets New Standard for Single-Cell Spatial …
Aug 10, 2022 · MONHEIM AM RHEIN, Germany – June 7, 2022 – Resolve Biosciences, the pioneer in Molecular Cartography TM, today announced the launch of its commercial …See details»
Resolve biosciences and ZEISS announce co-development …
Aug 3, 2021 · Resolve Biosciences, the pioneer in Molecular Cartography™, and ZEISS today announced a co-development collaboration to advance spatial biology applications. The …See details»
Resolve Biosciences (@ResolveBioSci) / X
The latest posts from @ResolveBioSciSee details»
RESOLVE
Leader of the Kuyendoya farmer-based organization, a mini-agricultural cooperative. At RESOLVE, we’re here to tackle the toughest global challenges. The ones nobody else wants …See details»
Resolve Therapeutics Publishes Positive Sjogren’s Syndrome …
St. Petersburg, FL – December 3, 2020 – Resolve Therapeutics, pioneering first-in-class, targeted, safe therapies for underserved autoimmune diseases, today announced publication …See details»
Press releases – Resolve Biosciences
Feb 21, 2021 · Life sciences tools veteran brings decades of experience leading successful teams, commercializing industry-defining technology platforms, and scaling global organizations.See details»
Resolve Therapeutics publishes positive Sjogren's syndrome …
Dec 3, 2020 · Resolve Therapeutics, pioneering first-in-class, targeted, safe therapies for underserved autoimmune diseases, today announced publication of results from its Phase 2 …See details»
Resolve Therapeutics Announces Completion of Enrollment for …
Jul 22, 2019 · Resolve Therapeutics is pioneering safe, targeted therapies for underserved autoimmune diseases with large unmet medical need. The Company’s lead compound, RSLV …See details»
Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis
Dec 10, 2020 · Company announces $24 million Series A financing and appoints Jason T. Gammack as CEO to accelerate development and commercialization of Molecular …See details»
Spatial biology – Resolve Biosciences
Scientists have been aware that spatial context matters in biology. Long before they had the technology to provide detailed data, there was an acceptance that biological …See details»